Word mark

Trademark: 'IMUTRAN' 
Imutran Ltd.
European Community Trademark, no. 000128397, Word mark


On 1. 4. 1996 the community trademark application no. 000128397 was filed for IMUTRAN (Word mark) by Imutran Ltd. before the OAMI.The goods and services in respect of which registration of the trademark was sought are in classes 5, 10, 29, 31, 40 and 42. The current status of the trademark is application withdrawn.

Status is 'Application withdrawn'
The Community Trade Mark application has been withdrawn by the applicant for whatever reason. So right now there is no protection of this very trademark ad you can file it.

Applied1. 4. 1996
Nice classes5, 10, 29, 31, 40, 42


You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.



Imutran Ltd.
21 Holborn Viaduct
EC1A 2DY London


If you are the trademark owner and the data above are not correct, then please update them soon by clicking on Update address.

If you want to transfer the trademark to another owner, click on Transfer trademark.

You can transfer a trademark partially or completely to another owner. A partial transfer means that you can transfer a trademark in specific classes.

Still questions? Call us : 0049 (0) 89 6666 10 89


20 Red Lion Street
WC1R 4PJ London


If the data above is not correct, then please choose Update.


Nice classes

5  Pharmaceutical preparations; preparations for use in transplantation (including genetically modified cells, tissues or organs); preparations for use in treating cancer; preparations for use in preventing or reducing complement activation or in activating complement; synthetic DNA; dressings.

10  Surgical, medical, dental and veterinary apparatus and instruments; surgical implants (including genetically modified cells, tissues and organs); suture materials; Ultra Violet Ray lamps for medical purposes.

29  Meat and meat extracts.

31  Live animals (including pigs).

40  Material treatment (including treatment of material to prevent or reduce the activation of complement).

42  Medical services (including transplantation surgery, cancer therapy and medical consultancy); medical clinics; diagnostic services; research and development services.